Company / EPS (Basic)
Enovis EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$20.75
FY2025
5-year range
-$20.75 / $1.40
FY2021-FY2025
Trend
-8200.0%
vs FY2024
Sector context
#157 of 160
Health Care
What the data says
EPS (Basic) changed -8200% YoY in FY2025, a notable deviation from the 9-year average annual change of -961%.
Based on SEC 10-K filings.
-20.75 in FY2025.
Declined from $1.40 to $-20.75 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 160This company -$20.75 Sector average $1.57
▼
-1418.0% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 8200.0% year-over-year.
- Ranks #157 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$20.75 | -8200.0% |
| FY2024 | -$0.25 | -117.9% |
| FY2023 | $1.40 | +50.5% |
| FY2022 | $0.93 | +123.9% |
| FY2021 | -$3.89 | -432.5% |
| FY2020 | $1.17 | -4.9% |
| FY2019 | $1.23 | +5.1% |
| FY2018 | $1.17 | -13.3% |
| FY2017 | $1.35 | -55.9% |
| FY2016 | $3.06 | +96.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026